Exomic analysis of myxoid liposarcomas, synovial sarcomas, and osteosarcomas

Genes Chromosomes and Cancer

Volumn 53, Issue 1, 2014, Pages 15-24

  Joseph, Christine G ^a   Hwang, Heejung ^a   Jiao, Yuchen ^a   Wood, Laura D ^a   Kinde, Isaac ^a   Wu, Jian ^a   Mandahl, Nils ^b   Luo, Jinyong ^c   Hruban, Ralph H ^a   Diaz, Luis A ^a   He, Tong Chuan ^d   Vogelstein, Bert ^a   Kinzler, Kenneth W ^a   Mertens, Fredrik ^b   Papadopoulos, Nickolas ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUND UNIVERSITY   (Sweden)

^c Ministry of Educations Key Laboratory of Clinical Diagnostic Medicine   (China)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3;

ADULT; AGED; AKT1 GENE; ARTICLE; CLINICAL ARTICLE; EXOME; FBXW7 GENE; FRAMESHIFT MUTATION; GENE; GENE MUTATION; GENETIC VARIABILITY; H3F3A GENE; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MYXOSARCOMA; NONSENSE MUTATION; OSTEOSARCOMA; PIK3CA GENE; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SETD2 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; SYNOVIAL SARCOMA; TP53 GENE;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CHILD; EXOME; HUMANS; LIPOSARCOMA, MYXOID; LOSS OF HETEROZYGOSITY; MIDDLE AGED; MUTATION; OSTEOSARCOMA; SARCOMA; SARCOMA, SYNOVIAL;

EID: 84887619842     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22114     Document Type: Article

References (38)

1. Agrawal N, Jiao Y, Bettegowda C, Hutfless SM, Wang Y, David S, Cheng Y, Twaddell WS, Latt NL, Shin EJ, Wang LD, Wang L, Yang W, Velculescu VE, Vogelstein B, Papadopoulos N, Kinzler KW, Meltzer SJ. 2012. Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov 2:899-905.
2. American Cancer Society. 2012. Cancer facts and figures 2012. American Cancer Society, 2012.
3. Barretina J, Taylor BS, Banerji S, Ramos AH, Lagos-Quintana M, Decarolis PL, Shah K, Socci ND, Weir BA, Ho A, Chiang DY, Reva B, Mermel CH, Getz G, Antipin Y, Beroukhim R, Major JE, Hatton C, Nicoletti R, Hanna M, Sharpe T, Fennell TJ, Cibulskis K, Onofrio RC, Saito T, Shukla N, Lau C, Nelander S, Silver SJ, Sougnez C, Viale A, Winckler W, Maki RG, Garraway LA, Lash A, Greulich H, Root DE, Sellers WR, Schwartz GK, Antonescu CR, Lander ES, Varmus HE, Ladanyi M, Sander C, Meyerson M, Singer S. 2010. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat Genet 42:715-721.
4. Bergh P, Meis-Kindblom JM, Gherlinzoni F, Berlin Ö, Bacchini P, Bertoni F, Gunterberg B, Kindblom L-G. 1999. Synovial sarcoma. Cancer 85:2596-2607.
5. Berman SD, Calo E, Landman AS, Danielian PS, Miller ES, West JC, Fonhoue BD, Caron A, Bronson R, Bouxsein ML, Mukherjee S, Lees JA. 2008. Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage. Proc Natl Acad Sci USA 105:6.
6. Bettegowda C, Agrawal N, Jiao Y, Sausen M, Wood LD, Hruban RH, Rodriguez FJ, Cahill DP, McLendon R, Riggins G, Velculescu VE, Oba-Shinjo SM, Marie SKN, Vogelstein B, Bigner D, Yan H, Papadopoulos N, Kinzler KW. 2011. Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 333:1453-1455.
7. Brown CJ, Lain S, Verma CS, Fersht AR, Lane DP. 2009. Awakening guardian angels: drugging the p53 pathway. Nat Rev Cancer 9:862-873.
8. Carpten JD, Faber AL, Horn C, Donoho GP, Briggs SL, Robbins CM, Hostetter G, Boguslawski S, Moses TY, Savage S, Uhlik M, Lin A, Du J, Qian YW, Zeckner DJ, Tucker-Kellogg G, Touchman J, Patel K, Mousses S, Bittner M, Schevitz R, Lai MH, Blanchard KL, Thomas JE. 2007. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 448:439-444.
9. Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AML, Gusterson BA, Cooper CS. 1994. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 7:502-508.
10. Coindre J-M, Pelmus M, Hostein I, Lussan C, Bui BN, Guillou L. 2003. Should molecular testing be required for diagnosing synovial sarcoma? Cancer 98:2700-2707.
11. Conyers R, Young S, Thomas DM. 2011. Liposarcoma: Molecular genetics and therapeutics. Sarcoma. 2011.
12. Ferrari A, Gronchi A, Casanova M, Meazza C, Gandola L, Collini P, Lozza L, Bertulli R, Olmi P, Casali PG. 2004. Synovial sarcoma: A retrospective analysis of 271 patients of all ages treated at a single institution. Cancer 101:627-634.
13. Goransson M, Andersson MK, Forni C, Stahlberg A, Andersson C, Olofsson A, Mantovani R, Aman P. 2008. The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-[kappa]B target genes by interaction with NFKBIZ. Oncogene 28:270-278.
14. Hansen MF, Koufos A, Gallie BL, Phillips RA, Fodstad O, Brogger A, Gedde-Dahl T, Cavenee WK. 1985. Osteosarcoma and retinoblastoma: A shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci USA. 82:5.
15. Je EM, Yoo NJ, Kim YJ, Kim MS, Lee SH. 2013. Somatic mutation of H3F3A, a chromatin remodeling gene, is rare in acute leukemias and non-Hodgkin lymphoma. Eur J Haematol 90:169-170.
16. Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, Volinia S, Stein GS, Croce CM, Lian JB, Aqeilan RI. 2012. miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res. 72:1865-1877.
17. Jones N, Iljin K, Dumont DJ, Alitalo K. 2001. Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol 2:11.
18. Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA Jr, Friedman AH, Friedman H, Gallia GL, Giovanella BC, Grollman AP, He TC, He Y, Hruban RH, Jallo GI, Mandahl N, Meeker AK, Mertens F, Netto GJ, Rasheed BA, Riggins GJ, Rosenquist TA, Schiffman M, Shih IeM, Theodorescu D, Torbenson MS, Velculescu VE, Wang TL, Wentzensen N, Wood LD, Zhang M, McLendon RE, Bigner DD, Kinzler KW, Vogelstein B, Papadopoulos N, Yan 2013. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci US A 110:6021-6026.
19. Kinde I, Wu J, Papadopoulos N, Kinzler KW, Vogelstein B. 2011. Detection and quantification of rare mutations with massively parallel sequencing. Proc Natl Acad Sci US A 108:9530-9535.
20. Malay Haldar RLR, Capecchi MR. 2008. Synovial sarcoma: From genetics to genetic-based animal modeling. Clin Orthop Relat Res 466:2156-2167.
21. Man TK, Lu XY, Jaeweon K, Perlaky L, Harris CP, Shah S, Ladanyi M, Gorlick R, Lau CC, Rao P. 2004. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Cancer 4:45.
22. Martin JW, Squire JA, Zielenska M. 2012. The genetics of osteosarcoma. Sarcoma 2012:11.
23. Nishio J, Iwasaki H, Nabeshima K, Naito M. 2011. Cytogenetics and molecular genetics of myxoid soft-tissue sarcomas. Genet Res Int 2011:13.
24. Oda Y, Sakamoto A, Satio T, Kawauchi S, Iwamoto Y, Tsuneyoshi M. 2000. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma. Mod Pathol13:994-1004.
25. Ohguri T, Hisaoka M, Kawauchi S, Sasaki K, Aoki T, Kanemitsu S, Matsuyama A, Korogi Y, Hashimoto H. 2006. Cytogenetic analysis of myxoid liposarcoma and myxofibrosarcoma by array-based comparative genomic hybridisation. J Clin Pathol 59:978-983.
26. Ottaviani G, Jaffe N. 2010. The epidemiology of osteosarcoma. In: Jaffe N, Bruland OS, Bielack S, editors. Pediatric and Adolescent Osteosarcoma, Vol. 152. US: Springer, pp. 3-13.
27. Overholtzer M, Rao PH, Favis R, Lu XY, Elowitz MB, Barany F, Ladanyi M, Gorlick R, Levine AJ. 2003. The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability. Proc Natl Acad Sci 100:11547-11552.
28. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA Jr, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW. 2008. An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807-1812.
29. Parsons DW, Li M, Zhang X, Jones S, Leary RJ, Lin JC, Boca SM, Carter H, Samayoa J, Bettegowda C, Gallia GL, Jallo GI, Binder ZA, Nikolsky Y, Hartigan J, Smith DR, Gerhard DS, Fults DW, VandenBerg S, Berger MS, Marie SK, Shinjo SM, Clara C, Phillips PC, Minturn JE, Biegel JA, Judkins AR, Resnick AC, Storm PB, Curran T, He Y, Rasheed BA, Friedman HS, Keir ST, McLendon R, Northcott PA, Taylor MD, Burger PC, Riggins GJ, Karchin R, Parmigiani G, Bigner DD, Yan H, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE. 2011. The genetic landscape of the childhood cancer medulloblastoma. Science 331:435-439.
30. Rago C, Huso DL, Diehl F, Karim B, Liu G, Papadopoulos N, Samuels Y, Velculescu VE, Vogelstein B, Kinzler KW, Diaz LA. 2007. Serial assessment of human tumor burdens in mice by the analysis of circulating DNA. Cancer Res 67:9364-9370.
31. Rosenberg AE, Cleton-Jansen A-M, de Pinieux G, Deyrup AT, Hauben E, Squire J. 2013. Conventional osteosarcoma. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, editors. WHO Classification of Tumours of Soft Tissue and Bone. Lyon: IARC Press, pp. 282-288.
32. Sandberg AA. 2004. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma. Cancer Genet Cytogenet 155:1-24.
33. Schneider-Stock R, Onnasch D, Haeckel C, Mellin W, Franke DS, Roessner A. 1999. Prognostic significance of p53 gene mutations and p53 protein expression in synovial sarcomas. Virchows Arch. 435:407-412.
34. Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DA, Tönjes M, Hovestadt V, Albrecht S, Kool M, Nantel A, Konermann C, Lindroth A, Jäger N, Rausch T, Ryzhova M, Korbel JO, Hielscher T, Hauser P, Garami M, Klekner A, Bognar L, Ebinger M, Schuhmann MU, Scheurlen W, Pekrun A, Frühwald MC, Roggendorf W, Kramm C, Dürken M, Atkinson J, Lepage P, Montpetit A, Zakrzewska M, Zakrzewski K, Liberski PP, Dong Z, Siegel P, Kulozik AE, Zapatka M, Guha A, Malkin D, Felsberg J, Reifenberger G, von Deimling A, Ichimura K, Collins VP, Witt H, Milde T, Witt O, Zhang C, Castelo-Branco P, Lichter P, Faury D, Tabori U, Plass C, Majewski J, Pfister SM, Jabado N. 2012. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482:226-231.
35. Spurrell EL, Fisher C, Thomas JM, Judson IR. 2005. Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital. Ann Oncol 16:437-444.
36. Suurmeijer A, de Bruijn D, Geurts van Kessel A, Miettinen MM. 2013. Synovial sarcoma. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, editors. WHO Classification of Tumours of Soft Tissue and Bone. Lyon: IARC, pp 213-215.
37. Tomasetti C, Vogelstein B, Parmigiani G. 2013. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation. Proc Natl Acad Sci USA 110:1999-2004.
38. Wunder JS, Gokgoz N, Parkes R, Bull SB, Eskandarian S, Davis AM, Beauchamp CP, Conrad EU, Grimer RJ, Healey JH, Malkin D, Mangham DC, Rock MJ, Bell RS, Andrulis IL.. 2005. TP53 mutations and outcome in osteosarcoma: A prospective, multicenter study. J Clin Oncol 23:1483-1490.